Form 4: LiveRamp Director Timothy Cadogan Acquires Shares as Part of Compensation
SEC Form 4
Director Timothy Cadogan acquired 1,216 shares of LiveRamp Holdings, Inc. as part of his compensation for serving as a director.
Summary
- On May 15, 2024, Timothy R. Cadogan, a director of LiveRamp Holdings, Inc., acquired 1,216 shares of common stock.
- The shares were issued as part of his compensation for service as a director.
- Following the transaction, Cadogan beneficially owns 52,232 shares of LiveRamp Holdings, Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company through compensation.
Positives
- The acquisition of shares by a director demonstrates alignment with the company's success.
Industry Context
This type of transaction is common for directors of publicly traded companies, who often receive stock as part of their compensation packages.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash and equity.
- The amount of equity granted varies based on company size, performance, and industry standards.
- Comparing LiveRamp's director compensation to that of similar companies in the data analytics and marketing technology space would provide further context.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholders as it demonstrates the director's alignment with the company's interests.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: Timothy Cadogan acquired shares of LiveRamp Holdings, Inc. |
| 05/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.